Moreover, in patients with lung, gastric, or breast cancer, PAR-1 expression was an independent, unfavorable prognostic factor in terms of overall survival, while in prostate cancer patients, it turned out to be a prognostic factor for local recurrence [17, 18, reviewed in 155]. The gene discussed is F2R; the disease is breast cancer.